Symbiotec Pharmalab IPO Final Subscription Status

Final subscription data from BSE & NSE with category-wise breakdowns

📈 Building steadily
📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at BSE & NSE · Registrar: MUFG Intime India Pvt. Ltd.
Listed Mainboard
Price: ₹938 - ₹988 Lot: 15 Min: ₹14,820 Period: 24 Aug - 27 Aug
Subscribed
75.05x
Total Demand
₹92,398 Cr
Applications
—
Build by Day
0.85x → 1.95x → 5.59x → 75.05x

Subscription (Shares)

CategoryOfferedAppliedTimes
QIB 35,50,608 64,33,59,195 181.20
NII 26,62,955 20,65,31,340 77.56
bNII (>10 Lakh) 17,75,304 15,50,46,495 87.34
sNII (2-10 Lakh) 8,87,651 5,14,84,845 58.00
Retail 62,13,562 8,47,65,465 13.64
Employee Reserved 33,408 5,44,845 16.31
TOTAL 1,24,60,533 93,52,00,845 75.05

Application Breakup

CategoryReservedApplicationsTimes
NII 12,681 9,83,483 77.56
bNII (>10 Lakh) 8,454 1,52,006 17.98
sNII (2-10 Lakh) 4,227 2,45,166 58.00
Retail 4,14,237 56,51,031 13.64
Employee Reserved 2,227 36,323 16.31
TOTAL 4,41,826 70,68,009 16.00

Subscription (Crores)

CategoryOfferedDemandTimes
QIB 350.80 63,563.89 181.20
NII 263.10 20,405.30 77.56
bNII (>10 Lakh) 175.40 15,318.59 87.34
sNII (2-10 Lakh) 87.70 5,086.70 58.00
Retail 613.90 8,374.83 13.64
Employee Reserved 3.30 53.83 16.31
TOTAL 1,231.10 92,397.84 75.05

Day-wise Subscription

End-of-day subscription.

Each panel has its own scale.
Day QIB NII bNII sNII Retail Emp. Total
Day 1 24 Aug 0.37x 1.10x 0.82x 1.66x 1.00x 1.65x 0.85x
Day 2 25 Aug 0.57x 3.16x 2.59x 4.30x 2.21x 3.19x 1.95x
Day 3 26 Aug 0.62x 12.83x 11.90x 14.69x 5.32x 6.21x 5.59x
Day 4 27 Aug 181.20x 77.56x 87.34x 58.00x 13.64x 16.31x 75.05x

Estimated Allotment Chance

Retail 8.4% (13.64x subscribed)
Low chance
S-HNI (2-10L) 1.7% (58.00x subscribed)
Low chance
B-HNI (>10L) 5.6% (87.34x subscribed)
Low chance
Employee 6.1% (16.31x subscribed)
Low chance
about 8 in 100 retail applicants are likely to get allotment.
Estimate from subscription data; the registrar's draw decides.

How Symbiotec Pharmalab’s demand compares with recent Mainboard IPOs

Final multiples against the 111 Mainboard IPOs listed in the last 12 months.

CategorySymbiotec PharmalabMainboard medianHigher than
Overall 75.05x 20.43x 74% of 111
QIB 181x 21.91x 81% of 111
NII (HNI) 77.56x 22.76x 66% of 110
Retail 13.64x 7.85x 59% of 106

Of the 15 recent Mainboard IPOs that finished 50x–100x subscribed, 93% opened above the issue price, with a median listing-day move of +18.8%. Symbiotec Pharmalab itself listed at +0%.

Source: BSE and NSE. Not investment advice.

Symbiotec Pharmalab IPO Subscription — Detailed Analysis

Where Symbiotec Pharmalab Subscription Finished

Symbiotec Pharmalab IPO was subscribed 75.05 times overall by the close of bidding — a heavily oversubscribed level that signals strong investor demand.

Symbiotec Pharmalab IPO Subscription — FAQs

Symbiotec Pharmalab IPO was subscribed 75.05 times overall by the close of bidding.

Symbiotec Pharmalab IPO was open for subscription from August 24, 2026 to August 27, 2026.

The price band for Symbiotec Pharmalab IPO is ₹938 - ₹988 per share.

See also: reading the subscription table · allotment chances · allotment process

GMPUpdate